News
Q3 2025 Earnings Call Transcript August 6, 2025 Cencora, Inc. beats earnings expectations. Reported EPS is $4, expectations were $3.85. Operator: Hello, everyone, and thank you for joining the Cencora ...
Cencora, Inc. (NYSE:COR) on Wednesday reported third-quarter 2025 sales increased 8.7% to $80.66 billion, beating the ...
Cencora (COR) recently announced strong third-quarter earnings with sales at $80,664 million and net income rising to $687 million, reflecting significant growth. Despite these robust results, the ...
Cencora, Inc. ( NYSE: COR) Q3 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Bennett S. Murphy - Senior VP, Head of Investor Relations & Treasury James F. Cleary - Executive VP & CFO Robert P ...
Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $250 billion in annual US healthcare distribution sales, the company supplies ...
23hon MSN
Cencora raises 2025 EPS guidance to $15.85–$16 and narrows outlook as specialty drives growth
Cleary announced, "We are raising and narrowing our fiscal 2025 EPS guidance and now expect EPS to be in the range of $15.85 to $16, up from the previous range of $15.70 to $15.95 and representing ...
Shares of Cencora Inc. COR shed 2.93% to $283.78 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.73% to 6,345.06 and ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...
U.S. drug distributor McKesson raised its annual profit forecast and beat Wall Street earnings estimates on Wednesday, ...
As of fiscal year-end 2025, McKesson held cash and cash equivalents of $5.7 billion with outstanding debt at $4.4 billion. Roughly one third of its debt is due to mature over the next three years, and ...
3h
Zacks Investment Research on MSNSTE Beats on Q1 Earnings and Revenues, Raises '26 Sales View
STERIS plc STE reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.34, up 15.3% from the year-ago ...
Chronic rare diseases are becoming a major challenge for the aging population in the United States. As life expectancy rises, healthcare needs become more complex, especially for conditions that are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results